Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07433634 · ClinicalTrials.gov registry record
Time to BBVNA Relief
A clinical trial of Low Back Pain and Vertebrogenic Pain Syndrome, sponsored by Yale University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 3
- Study locations
NCT07433634: Recruiting study of Low Back Pain and Vertebrogenic Pain Syndrome, sponsored by Yale University.
NCT07433634 is a study of Low Back Pain and Vertebrogenic Pain Syndrome that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, below the 502-participant average among 122 other Low Back Pain trials with a reported enrollment target (60% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07433634, a study of Low Back Pain and Vertebrogenic Pain Syndrome, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 3
- Study locations
Study Summary
Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.
Primary Outcome
Clinical response defined as a ≥50% reduction in pain intensity from baseline as measured by the Visual Analog Scale (VAS) or a ≥15-point improvement in the Oswestry Disability Index (ODI) score
Conditions Studied
Interventions
- PROCEDURE Basivertebral nerve ablation
Study Locations (3)
Connecticut
- Yale Spine and Pain Center - Guilford - Guilford
- Yale Pain Management Center - New Haven - New Haven
- Yale Interventional Spine and Musculoskeletal Medicine - Old Saybrook - Old Saybrook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-04-19 |
| Est. Completion | 2026-10 |
What NCT07433634 shows while recruiting
NCT07433634 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 502-participant average among 122 other Low Back Pain trials with a reported enrollment target (60% lower).
The record links to 3 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Basivertebral nerve ablation is the first listed.
NCT07433634 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07433634 about?
NCT07433634 is a clinical study titled "Time to BBVNA Relief". Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors o...
What is the current status of trial NCT07433634?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-04-19. Estimated completion is 2026-10.
What conditions does trial NCT07433634 study?
This clinical trial studies the following conditions: Low Back Pain, Vertebrogenic Pain Syndrome, Basivertebral Nerve Ablation.
What interventions are being tested in trial NCT07433634?
The interventions under investigation include: Basivertebral nerve ablation (PROCEDURE).
Who is sponsoring clinical trial NCT07433634?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07433634 being conducted?
This trial has 3 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07433634's enrollment target sits among peer trials
200 30th of 122 higher than 92 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Opioid Response to Injections
RECRUITING · Phase 4
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
Evaluation of the Effects of a Rehabilitation Program in Individuals with Spine Pain
RECRUITING
-
The Spine Phenome Project
RECRUITING
-
Overlapping Pain Trajectory Study
RECRUITING
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI